Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952170 · ClinicalTrials.gov registry record · NA
Impact of Weight Loss Surgery in Adolescents With NAFLD
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02952170: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02952170 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02952170, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will assess the impact of weight loss surgery (WLS) on non-alcoholic fatty liver disease (NAFLD) in adolescents as well as the interaction between NAFLD and cardiometabolic risk.
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-09-15 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02952170
The ClinicalTrials.gov registry entry for NCT02952170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02952170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02952170 about?
NCT02952170 is a clinical study titled "Impact of Weight Loss Surgery in Adolescents With NAFLD". This study will assess the impact of weight loss surgery (WLS) on non-alcoholic fatty liver disease (NAFLD) in adolescents as well as the interaction between NAFLD and cardiometabolic risk.
What is the current status of trial NCT02952170?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-09-15. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT02952170?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT02952170?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.